Delivery Order SPE2DB22D3501-SPE2DB25FUX72
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,501.10 to AmerisourceBergen Drug Corp for Potassium Phosphate 45 mmol/15 ml pharmaceutical product on July 23, 2025, with completion scheduled for July 24, 2025. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award to this major pharmaceutical distributor. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a $3,390.17 delivery order to AmerisourceBergen Drug Corp for potassium phosphate 45 mmol/15 ml pharmaceutical product on August 5, 2025, with ultimate completion targeted for August 6, 2025. This firm fixed-price, non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026. The place of performance is...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,119.11 to AmerisourceBergen Drug Corp for the supply of Potassium Phosphate 15 mmol/5 ml in 5 ml vials. This firm fixed-price, competitively awarded delivery order was issued on August 28, 2025, with an ultimate completion date of August 29, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents no set-aside designation and falls under standard...
- The Defense Logistics Agency awarded a $4,858.53 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Potassium Phosphate 15 mmol/5 mL in 5 mL vials. The contract, which is classified as a non-set-aside competitive award, has an ultimate completion date of September 11, 2025, and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. This delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $1,385.30 delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Potassium Phosphate 15 mmol/5 ml in 5 ml vials. This firm fixed-price contract, with an ultimate completion date of August 15, 2025, will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. The award was not set aside and represents a competitive procurement action under the company's existing contract vehicle with the agency. This delivery order...
- The Defense Logistics Agency awarded a $1,842.03 delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Potassium Phosphate 45 mmol/15 ml pharmaceutical product. This firm fixed price, non-set-aside contract is scheduled for completion by September 4, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, holds a significant indefinite...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for potassium phosphate 15 mmol/5 ml vials valued at $4,328.93 on August 12, 2025. This firm fixed-price delivery order, which is not set-aside, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania, with completion scheduled for August 13, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, is the...
- The Defense Logistics Agency awarded a delivery order valued at $7,184.64 to AmerisourceBergen Drug Corp for the supply of Potassium Phosphate 45 mmol/15 ml in 15 ml units. This is a firm fixed price delivery order with an ultimate completion date of September 19, 2025, and no set-aside designation was used in the award. The vendor will perform the work at its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp Corporate Office Division. The $2,584.67 Firm Fixed Price Delivery Order is for the supply of 4566105390 - Potassium Phosphate 45 mmol/15 ml, 15 ml. The award does not have a set-aside designation and has an ultimate completion date of October 16, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds a significant Indefinite...
- The Defense Logistics Agency awarded a $819 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 45mmol/15ml potassium phosphate injectable solution. As the prime contractor, Amerisourcebergen will supply the product to the DLA under a one-day period of performance beginning August 2nd and concluding August 3rd, 2023. The place of performance will be Amerisourcebergen's Conshohocken, Pennsylvania facility. No subcontractors or set aside designations were indicated. This...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FUX72Delivery Order
The Defense Logistics Agency awarded a $5,932.16 firm fixed-price delivery order to AmerisourceBergen Drug Corp on March 14, 2025, for the supply of Potassium Phosphate 45 mmol/15 ml in 15 ml units, with performance completion targeted for March 17, 2025. This non-set-aside competitive award is performed at the vendor's corporate office location in Conshohocken, Pennsylvania, and represents a child delivery order under AmerisourceBergen's larger contract vehicle with the DLA. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, holds a substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX) valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle serves as a comprehensive global pharmaceutical support mechanism enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard. The current delivery order for potassium phosphate represents a routine fulfillment of the company's critical role in the federal medical supply chain, consistent with its extensive portfolio of competitive pharmaceutical awards across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.9k | 3/14/25 |